A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)

Autor: Wirta, David L., Senchyna, Michelle, Lewis, Amber E., Evans, David G., McLaurin, Eugene B., Ousler, George W., Hollander, David A.
Zdroj: In The Ocular Surface October 2022 26:166-173
Databáze: ScienceDirect